329 related articles for article (PubMed ID: 2553433)
1. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
Hiramatsu M; Cho AK; Nabeshima T
Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
[TBL] [Abstract][Full Text] [Related]
2. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
Marquis KL; Paquette NC; Gussio RP; Moreton JE
J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
[TBL] [Abstract][Full Text] [Related]
3. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
Koek W; Woods JH; Winger GD
J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
[TBL] [Abstract][Full Text] [Related]
4. Phencyclidine-like discriminative stimulus properties of MK-801 in rats.
Willetts J; Balster RL
Eur J Pharmacol; 1988 Jan; 146(1):167-9. PubMed ID: 3280331
[TBL] [Abstract][Full Text] [Related]
5. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice.
Irifune M; Shimizu T; Nomoto M; Fukuda T
Pharmacol Biochem Behav; 1995; 51(2-3):291-6. PubMed ID: 7667342
[TBL] [Abstract][Full Text] [Related]
6. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
[TBL] [Abstract][Full Text] [Related]
7. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats.
Scalzo FM; Burge LJ
Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359
[TBL] [Abstract][Full Text] [Related]
8. Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?
Jackson A; Sanger DJ
Psychopharmacology (Berl); 1988; 96(1):87-92. PubMed ID: 2906445
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
10. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
[TBL] [Abstract][Full Text] [Related]
11. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
[TBL] [Abstract][Full Text] [Related]
12. In vivo characterization of phencyclidine/sigma agonist-mediated inhibition of nociception.
DeLander GE; Wahl JJ
Eur J Pharmacol; 1989 Jan; 159(2):149-56. PubMed ID: 2468511
[TBL] [Abstract][Full Text] [Related]
13. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
Koek W; Colpaert FC; Woods JH; Kamenka JM
J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416
[TBL] [Abstract][Full Text] [Related]
14. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
15. Phencyclidine receptor ligands attenuate cortical neuronal injury after N-methyl-D-aspartate exposure or hypoxia.
Goldberg MP; Viseskul V; Choi DW
J Pharmacol Exp Ther; 1988 Jun; 245(3):1081-7. PubMed ID: 2838603
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of dopaminergic pathways in the mesocortex by compounds that act at the phencyclidine (PCP) binding site: tentative evidence for PCP recognition sites not coupled to N-methyl-D-aspartate (NMDA) receptors.
Rao TS; Kim HS; Lehmann J; Martin LL; Wood PL
Neuropharmacology; 1990 Mar; 29(3):225-30. PubMed ID: 2158000
[TBL] [Abstract][Full Text] [Related]
17. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
Sanger DJ; Jackson A
J Pharmacol Exp Ther; 1989 Mar; 248(3):1215-21. PubMed ID: 2649656
[TBL] [Abstract][Full Text] [Related]
18. Phencyclidine and (+)-MK-801-induced circling preference: correlation with monoamine levels in striatum of the rat brain.
Ali SF; Newport GD; Bracha HS
Neurotoxicol Teratol; 1994; 16(4):335-42. PubMed ID: 7968937
[TBL] [Abstract][Full Text] [Related]
19. The topography of MK-801-induced locomotor patterns in rats.
Ford LM; Norman AB; Sanberg PR
Physiol Behav; 1989 Oct; 46(4):755-8. PubMed ID: 2557649
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and behavioral effects of sigma and PCP ligands.
Contreras PC; Contreras ML; O'Donohue TL; Lair CC
Synapse; 1988; 2(3):240-3. PubMed ID: 2850629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
